Vichinsky E, Hoppe CC, Ataga KI, et al. Results from the randomized placebo-controlled phase 3 HOPE trial of voxelotor in adults and adolescents with sickle cell disease. 24th Congress of EHA, abstract S147.
Apixaban geassocieerd met lager risico op posttrombotisch syndroom na diepveneuze trombose
apr 2026 | Benigne hematologie